Tributyltin induces G2/M cell cycle arrest via NAD<sup>+</sup>-dependent isocitrate dehydrogenase in human embryonic carcinoma cells
-
- Asanagi Miki
- Division of Pharmacology, National Institute of Health Sciences Faculty of Engineering, Department of Materials Science and Engineering, Yokohama National University
-
- Yamada Shigeru
- Division of Pharmacology, National Institute of Health Sciences
-
- Hirata Naoya
- Division of Pharmacology, National Institute of Health Sciences
-
- Itagaki Hiroshi
- Faculty of Engineering, Department of Materials Science and Engineering, Yokohama National University
-
- Kotake Yaichiro
- Department of Xenobiotic Metabolism and Molecular Toxicology, Graduate School of Biomedical and Health Sciences, Hiroshima University
-
- Sekino Yuko
- Division of Pharmacology, National Institute of Health Sciences
-
- Kanda Yasunari
- Division of Pharmacology, National Institute of Health Sciences
Bibliographic Information
- Other Title
-
- Tributyltin induces G2/M cell cycle arrest via NAD⁺-dependent isocitrate dehydrogenase in human embryonic carcinoma cells
Search this article
Abstract
Organotin compounds, such as tributyltin (TBT), are well-known endocrine-disrupting chemicals (EDCs). We have recently reported that TBT induces growth arrest in the human embryonic carcinoma cell line NT2/D1 at nanomolar levels by inhibiting NAD+-dependent isocitrate dehydrogenase (NAD-IDH), which catalyzes the irreversible conversion of isocitrate to α-ketoglutarate. However, the molecular mechanisms by which NAD-IDH mediates TBT toxicity remain unclear. In the present study, we examined whether TBT at nanomolar levels affects cell cycle progression in NT2/D1 cells. Propidium iodide staining revealed that TBT reduced the ratio of cells in the G1 phase and increased the ratio of cells in the G2/M phase. TBT also reduced cell division cycle 25C (cdc25C) and cyclin B1, which are key regulators of G2/M progression. Furthermore, apigenin, an inhibitor of NAD-IDH, mimicked the effects of TBT. The G2/M arrest induced by TBT was abolished by NAD-IDHα knockdown. Treatment with a cell-permeable α-ketoglutarate analogue recovered the effect of TBT, suggesting the involvement of NAD-IDH. Taken together, our data suggest that TBT at nanomolar levels induced G2/M cell cycle arrest via NAD-IDH in NT2/D1 cells. Thus, cell cycle analysis in embryonic cells could be used to assess cytotoxicity associated with nanomolar level exposure of EDCs.
Journal
-
- The Journal of Toxicological Sciences
-
The Journal of Toxicological Sciences 41 (2), 207-215, 2016
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679882646016
-
- NII Article ID
- 130005132668
-
- NII Book ID
- AN00002808
-
- ISSN
- 18803989
- 03881350
-
- NDL BIB ID
- 027267871
-
- PubMed
- 26961604
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed